Infratentorial Ependymoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2015-03-23
Clinical Trial Update: Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma [Phase 2]
Phase 2 trial of sunitinib malate in children with recurrent, refractory, or progressive malignant gliomas and ependymomas has completed; re…